Limpet

Glimepiride USP

Composition : Limpet-1: Glimepiride USP 1mg Tablet.

Limpet-2: Glimepiride USP 2mg Tablet.

Limpet-3: Glimepiride USP 3mg Tablet.

Limpet-4: Glimepiride USP 4mg Tablet.

Indication :Limpet is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin dependent (Type-II) diabetes mellitus (NIDDM) whose hyperglycaemia cannot be controlled by diet and exercise alone. Limpet may be used concomitantly with metformin when diet, exercise, and Limpet or metformin alone do not result in adequate glycemic control. Limpet is also indicated for use in combination with insulin to lower blood glucose in patients whose hyperglycaemia can not be controlled by diet and exercise in conjunction with an oral hypoglycaemic agent.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.

Dosage and administration : The usual starting dose of Limpet as initial therapy is 1- 2mg once daily, administered with breakfast or the first main meal. The usual maintenance dose is 1-4mg once daily. The maximum recommended dose is 8mg once daily. or, as directed by the registered physicians.

Use in pregnancy and lactation : Limpet has been assigned to pregnancy category C by the FDA.

Packing :

Limpet-1 : 4 x 14's tablets in blister pack

Limpet-2 : 4 x 14's tablets in blister pack.

Limpet-3 : 2 x 14's tablets in blister pack.

Limpet-4 : 2 x 14's tablets in blister pack.

Prescribing Description

Related Products

© Copyright Drug International Ltd. 2024 Designed and Developed by ATI Limited.